Clinical Trials Browser

NETWORK × cemiplimab × Clear all

NCT06931717 2026-03-18

ARCH

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06219317 2026-02-23

ICARS

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung